SCHEMBL30385681

SCHEMBL30385681

Nc1ccnc(C2CCCC2)c1N

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDO2 P48775 3/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CYP11B2 P19099 1/20 0.33
▸ CAMKK2 Q96RR4 1/20 0.33
▸ NCF1 P14598 1/20 0.32
▸ HRH2 P25021 1/20 0.32
▸ HRH3 Q9Y5N1 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ FFAR2 O15552 2/20 0.31
▸ DGAT1 O75907 1/20 0.31
▸ OPRL1 P41146 1/20 0.31
▸ JAK2 O60674 2/20 0.31
▸ JAK1 P23458 2/20 0.31
▸ TYK2 P29597 2/20 0.31
▸ JAK3 P52333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15740688 1.00 TDO2 (0.34) TDO2NPC1LMNATP53PKM
SCHEMBL15740601 0.98 TDO2 (0.36) TDO2NPC1LMNATP53PKM
SCHEMBL15740579 0.96 NCF1 (0.32) TDO2NPC1LMNATP53PKM
SCHEMBL927943 0.91 NCF1 (0.34) LMNASMN1; SMN2NCF1HRH3OPRL1
SCHEMBL4142576 0.82 MKNK1 (0.42) PKMHRH3JAK2JAK1TYK2
SCHEMBL18978716 0.82 OPRL1 (0.35) OPRL1
SCHEMBL27722066 0.82 TDO2 (0.35) TDO2NPC1LMNATP53PKM
SCHEMBL27834997 0.81 TDO2 (0.37) TDO2NPC1LMNATP53PKM
SCHEMBL22236056 0.80 GAA (0.42) SMN1; SMN2HRH3JAK1FLT3HRH4
SCHEMBL31570620 0.79 FEN1 (0.38) TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023084449-A1 DIAMINOCYCLOPENTYLPYRIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER NOVARTIS AG (CH) 2023-05-19 — — WO disclosed
WO-2023084449-A1 DIAMINOCYCLOPENTYLPYRIDINE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER NOVARTIS AG (CH) 2023-05-19 — — WO disclosed
Send feedback